Project Grant R01AG092357
Award Date
12/1/24
Completion Date
11/30/29
Dollars Obligated
$689K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10021, USA
Similar Awards
This Project Grant award of $2,549,716.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research by New York University School of Medicine to investigate the role of inflammation in the decline of skeletal stem and progenitor cell function during aging. The goal is to identify therapeutic targets to improve bone health and fracture repair in elderly patients. Key focus areas include: Defining the molecular mechanisms regulating the inflammatory response in skeletal...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $599,693 to The Hospital For Special Surgery Fund, Inc. (HSS Foundation) from August 1, 2024 to July 31, 2029. The award supports research to elucidate molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis, with the goal of developing new...
This Project Grant award of $110,992.00, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), supports research to investigate the role of hypoxia-inducible factor-2A (HIF-2A) signaling in driving osteocyte senescence and age-related bone loss. The research, conducted by the University of California, Davis, aims to elucidate the mechanistic coupling between HIF-2A and cellular senescence markers in osteocytes, and demonstrate that HIF-2A deletion...
The National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), awarded a $299,428 Project Grant to WNT Scientific LLC to develop an innovative medical device to treat nonunion fractures in older adults. The device is a biodegradable, controlled-release material designed to promote fracture healing by stimulating angiogenesis (blood vessel formation), which is impaired in elderly patients due to chronic inflammation. The awarded project aims to commercialize this...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund research to investigate the mechanisms by which mechanical and hormonal signals are integrated within bone cells to stimulate bone formation. The total award amount is $175,948 and will be performed over 5 years from June 1, 2025 to May 31, 2030. The research aims to identify how the focal...
This federal Project Grant award in the amount of $719,873 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The funding supports research to investigate how epigenetic deregulation of osteoblasts in the bone marrow stroma promotes age-related clonality and transformation of hematopoietic cells harboring IDH1/2 mutations, which can...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $2,541,656 to the Mayo Clinic in Rochester, Minnesota to conduct research on characterizing senescent cell populations in skeletal aging. The goal is to leverage novel tools and mouse models to better define the mechanisms driving cellular senescence in the bone microenvironment and identify key senescent cell populations that contribute to age-related bone loss and other aging comorbidities. A...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to identify myeloid progenitors that maintain cortical bone mass with age and characterize factors that promote coupling within cortical bone. The $375,100 award, active from Sep 20, 2024 to Aug 31, 2026, supports research at the University of Minnesota to address the significant impact of...
This $313,000 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund research by Emory University to establish phosphorylated WNT5A produced by osteoclasts as a potential anabolic bone drug. The research aims to determine how osteoclast-derived phospho-WNT5A can enhance bone formation in vivo and elucidate the cellular and molecular mechanisms by...
This federal Project Grant award, valued at $626,879.00, was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research aims to explore a novel mouse model of large-scale bone regeneration to unravel the cellular and molecular mechanisms governing the initiation and coordination of bone repair following extensive injuries. Specifically, the research will...